| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |